Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Dry Eye Disease (DED)
Clinical Trial
Last updated: 12/4/2025
Champix
Champix is indicated for smoking cessation in adults.
OYST
Oyster Point Pharma, Inc.
